Advertisement

Psychiatry Weekly, 5(10). April 19, 2010

Previous Issue     Archives: -Select Year- 2010 2009 2008 2007 2006 Next Issue

 

• Neuroplasticity and Experimental Treatment Paradigms
• Longevity Genes
• The High Cost of Psychiatric Training: Psychiatry is Losing Many of the Best and Brightest
• DSM-IV Criteria for MDD: How Often Do Physicians Use Them?
• Psychiatric Follow-Up Post-Traumatic Brain Injury
• IQ, Cognitive Function, First-Episode Schizophrenia
• FDA Approves Doxepin for the Treatment of Insomnia
• Practical Dosing Strategies in the Treatment of Schizophrenia: Part 2 - Switching and Combining Antipsychotics
• Psychosocial and Neural Correlates of Resilience
• Targeting Specific Patient Beliefs of Insomnia

 

The Glutamate System: A Breakdown of the Neurobiology, and Current Therapeutic Research Exposure and Response Therapy Designed for Pediatric OCD Mental Health Literacy and Depression Outcomes

Proposed Revisions of Dementia Diagnostic Categories for DSM-5 How Might A Smoke-Free Policy Affect A Large Psychiatric Hospital?

The Treatment Challenges of Adult Patients with ADHD Stressful Life Events and Depression Risks: A Twin Study Sleeping Pills and Anxiolytics Associated with Greater Mortality Risks Is Poor Social Cognition Linked to Prodromal Schizophrenia?